wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q34180815-96886E89-F6BB-436F-B757-025AAD052A33
Q34180815-96886E89-F6BB-436F-B757-025AAD052A33
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34180815-96886E89-F6BB-436F-B757-025AAD052A33
A phase 2 trial of dacomitinib (PF-00299804), an oral, irreversible pan-HER (human epidermal growth factor receptor) inhibitor, in patients with advanced non-small cell lung cancer after failure of prior chemotherapy and erlotinib.
P2860
Q34180815-96886E89-F6BB-436F-B757-025AAD052A33
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34180815-96886E89-F6BB-436F-B757-025AAD052A33
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
68cd94e2bcd7524cdf1471d791f42f626d5c321b
P2860
HER2 mutations in non-small-cell lung cancer can be continually targeted.